Taste Physiology in Obese Volunteers Before and After Bariatric Surgery
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Bettina Wölnerhanssen, Dr
- Email: bettina.woelnerhanssen@usb.ch
Study Locations
-
-
-
Basel, Switzerland
- Recruiting
- University Hopital Basel
-
Contact:
- Bettina Wölnerhanssen, Dr
- Email: bettina.woelnerhanssen@usb.ch
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- morbidly obese patients (BMI min 35kg/m2) scheduled for bariatric surgery
- right handed
Exclusion Criteria:
- cardiovascular disease
- neurologic/psychiatric disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo preoperative
Single intragastric instillation of 200ml tap water via nasogastric tube
|
Tap water 200ml
|
|
Placebo Comparator: Placebo postoperative
Single intragastric instillation of 200ml tap water via nasogastric tube
|
Tap water 200ml
|
|
Active Comparator: Glucose preoperative
Single intragastric instillation of 200ml tap water with 25g glucose via nasogastric tube
|
25g Glucose in 200ml tap water
|
|
Active Comparator: Glucose postoperative
Single intragastric instillation of 200ml tap water with 25g glucose via nasogastric tube
|
25g Glucose in 200ml tap water
|
|
Active Comparator: Monosodium glutamate preoperative
Single intragastric instillation of 200ml tap water with 1g monosodium glutamate via nasogastric tube
|
1g monosodium glutamate in 200ml tap water
|
|
Active Comparator: Monosodium glutamate postoperative
Single intragastric instillation of 200ml tap water with 1g monosodium glutamate via nasogastric tube
|
1g monosodium glutamate in 200ml tap water
|
|
Active Comparator: Quinine preoperative
Single intragastric instillation of 200ml tap water with 17mg quinine via nasogastric tube
|
17mg quinine in 200ml tap water
|
|
Active Comparator: Quinine postoperative
Single intragastric instillation of 200ml tap water with 17mg quinine via nasogastric tube
|
17mg quinine in 200ml tap water
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Effect of tastants on cerebral blood flow measured by functional brain MRI
Time Frame: changes from baseline to one hour after treatment
|
changes from baseline to one hour after treatment
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Effect of tastants plasma glucagon-like peptide (GLP-1) concentrations
Time Frame: changes from baseline to one hour after treatment
|
changes from baseline to one hour after treatment
|
|
Effect of tastants plasma ghrelin concentrations
Time Frame: changes from baseline to one hour after treatment
|
changes from baseline to one hour after treatment
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Christoph Beglinger, Prof, University Basel
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimated)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- fMRI Taste 2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.